| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |